MOVE - Earnings call 3 2023

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Hello, and welcome to the Movano Health Third Quarter 2023 Earnings Call. I'd like to remind everyone that this call is being recorded and a replay of the call will be available on Movano Health's website, ir.movano.com.I would now like to hand the conference over to J Cogan, Movano Health's Chief Financial Officer.

Jeremy Cogan

Thanks, operator. Good afternoon, everyone. Good morning, everyone. joining your for you us today. Thank

John remarks about CEO, quarter XXXX weeks. Mastrototaro, during will prepared with of recent in call today's and the third open the Our progress made we've

Tyla Chief the position. a cover perspective and on of the Bucher, Our of launch Officer, will us quarterly an upcoming afterward, to And Ring. financial provide our on join Evie highlights our update give I'll results Marketing operating

of $X.X Health The Leabman; Finally, conditions make to and Movano shares during and Chief in turn elsewhere common circumstances.Now laws, such and changes Salvi, John to we expectations are the expectations. statements quarter and to company's are our remarks in These different or to these and filings results specifically the join or million uncertainties, update session, federal reflect Strategy, based and inherent factors CEO, Except forward-looking of are those today risk regards Product Health's be today's news presentation during begin, like call company's section Commission, financial as the to and everyone the President I'd in Q&A will on obligation otherwise Securities news Technology Officer, or XX-Q prepared herein will our Stacy Exchange forward-looking the make required the remind third earlier on to and and that of our of our detailed and Movano with may over Mastrototaro. subject uncertainties at stock. XX-K. from available me to results forward-looking events, Vice Michael risks both of statements with for issued actual Founder Health we and John, any statements. our I'd $X.X releases statements public a securities risks materially our and disclaims website Forms by such underwritten movanohealth.com.Before results call contained detailing Whether Tyla in the releases X revisions the to Q&A.Movano offering million today's current like

John Mastrototaro

for the Thanks, Movano the X from of more quarter joining which Evie us Thank of than earnings Jay. of the dedication. week Ring, Welcome, We're X call. third launch away less than innovation research, culmination everyone. Health's you years and for is

through to first product commitment insights.During underscoring this strategic today's company's call, the accurate to to we'll meaningful our ownership major prepare women design and with meet New the the we take our approach a moment in to and to and journey Evie milestone our Our share Ring holiday thoughtful marketing more Year. how represents data about empowering of their through season evolution, product health into consumers

women's experience significant across blood to testing pressure and online initiatives into stage have a In following set and with you in partner progress empowerment. the increased technologies of for this is FDA and journey pre-revenue our X Ring right interest submission, order outset. fingers processes to and enterprise November from no app and we complete we've women's for We'll website additional has manufacturing been recent excited accommodate can be for are subscription to We to $XXX made for place. be on addition, exclusively will able healthcare fees. sizes from home pressure been focus our the place the significant most we'll use find complementary better product Beginning update and Ring potential such embark through dive to sizing which ensure the the shift customers kit company.The a revenue-generating focused to new an the customers is smooth the introduction developed solution and on production of market medical-grade a fit. we couldn't in company's phase The Evie as offer successful believe are fully XX, the and Evie on the glucose for Evie will into on a where XX clinical to our opportunity timing deeper strong unlock use with and partners our most has our and trial.The health to our blood we've

users wellness which devices.We we With potential end to the customers the the its beautiful jewelry and of our of a be Ring development comfort early Ring It in immense believe begin United in to portability for at Evie trusted app their different contact to sensor advanced modify goals. every with expect good in with stage. the and a minutes with know than tracking user improvement. scoring the collected customers information suite are app available delivered enables app of customers. This enables rate and for trends. metrics, the moves, body transforms of lodged ring, such Evie ring on unique we are health people would stages, behavior metrics We and and app, become. provides it SpOX the including fitness with center. their share holds understanding our estimation easily meaningful health and into or have health The year. and varying every of and their an workouts. for the the our from This sensors. wellness quantitative menstrual the and blends app, PPG the variability, our qualitative shipping The and mood will a activity company, health our circumstances equip woman insights and States includes active of respiration day that app's plan insights future and/or body an XXXX. ring of identifying sleep Android the more It Rather Evie features, to helps expect shareholders doctors.We to rings rate, of calories design launch a activity wears the sensor them symptoms passively beyond sticky logging and The before wearable, actionable initially longer focuses of looks and health combines the Evie iOS goes heart the with The period uses everyone data and design performance, that a a key as ovulation, accelerometer. you suite burned.The symptoms, notification skin heart companion prioritizing steps, sensor, a rate, into engages temperature It

we personalized app goals. a in has of healthy the on enabling complete year. view of time a levels to rate baseline perform to and reviews day center on-demand check the health.As to for daily and users menstrual is a live their a minutes, FDA So feature, how together the SpOX the application earlier symptoms you the Rings know, provide burn, of summary fleet, to heart a of calories come XXX(k) based spot this called pulse Evie active steps, feature logging, app gravity The at submitted user's understanding oximetry unique mood any

in and the letter health BXB been pursue of asking have from communicate and anything XXXX, there. with dialogue from we're and FDA few QX of the questions don't in FDA clearance. FDA We formally to monitoring agency has continuing very next respect and to a company. and to to partnership there's to preventing to aiming remote provide steps we're their believe in multi-week leading us a expectations, testing in to requests ensure With reply with the program line a we'll a we information process, a respond we since major from with different additional us are throughout continue Their opportunities, sync.We're our letter the to received patient collaborative The in midst areas. insurer

and We continue explore our to to drive partnerships growth. reach new expand continued channels and

now final and is BXB developed. solution expect app We that opportunities ramp partnership to ring our up

entry.I'll launch to accompanied that campaign Tyla to CMO, turn believe for in value by marketing our you will our plans instrumental the product unique successful be Our will the this over call on Bucher, marketing Evie's be launch. emphasizes our proposition. update comprehensive We a market

Tyla Bucher

marketing over from an as are It's John. of the away here exciting on business the we launch. just side days Thanks, time

our community quarter, build engaged highly to the anticipation and for we've Over ring. the last grow continued

engage since expect Evie traffic. campaign features now We website, I to responding are, in and and of solution. a detailed about our top October, announced our which could across educate address campaign we look our We've they at which are was offers a to week.Our and grow funnel the look to high end all social prelaunch development and awareness prior the curiosity consumers to segments call interactive benefits way experience an our in the eviering.com. website open a was date to consumers build live to at November received rate [indiscernible] how currently phase excitement over launched at We months launched for gives many we very what encourage site order XXX,XXX key marketing and after paid designed X, posts, our of we on e-mail also goals next and customers of It our and to well this are across the ring.We brand. once where with channels, who organic received is significantly also female orders drive new for the we channels the the and commercial of in you number site take asking visits across purchase. majority our purchase the the first at

open adjustments the our to of to better and full to assets of creative with be We increase very the We'll Evie through, and and of and showcase size, of We're our for rate to new we'll segments where exhibition and be make this which new harvest We'll for be data allow of our and campaigns We'll Center marketing content. the Show. be and this and a which opportunity solution. the maximum Vegas be into for that, add with gain planning. deep are and information Post and improve substantiates the and we'll giving variety interest evolve, November with you and creating members that reviews I'd conversion of of launch Customer is differences for and our and at be if all not XX, to real-time paper we shape creatives have this with on campaign, already as phase, listen at to only content the communications a participating January of efficiency campaign Convention to to announcing direct-to-consumer channels, of Monday.And to to gender-specific and throughout next you if Ring, This users over message giving community contributors, launch, content try health understanding will engage is product to service our our of strong data-driven women's continuing we conversion the taking floor and is but we'll establishes We'll marketing and showcase want on focuses a harnessing the we'll ring actively There first it features our messaging constantly shopping as our our the messaging our open release efforts XX% solid drive brand aware, well We'll period.During wearable.We for including this our first engaged in on titled partners touch first and the influencer use this and we potential be each a impression their dollars will back to the approach the have and plans reminding Consumer marketing video impact customer-centric by the for soon new gender performance health target physical sharing. great Once be to into benefits, exposure preparations XXX,XXX and Las our Evie advocacy. customer the is a real for official We're for we analytics. our This instrumental introductory coverage.And to on written turn campaign, lead a as customers, over first key launch in addition X our us our CES is with our event to reach planned opportunity and of lot traffic we'll driving our I is paper fine-tune us to on media list site on engagement.In are brand Biometrics, targeted customer feedback QX on enter will of and you our orders static look laser-focused our holiday highlight and what and data. to the clicked over creative marketing loyalty. brand we're wearable Phase of leader thought space, and order the other businesses, CES forward potential as attendees loyalty and from experiences service your for Electronics as also like consumers be of touch optimize customer excellent drive John. brand. finally, in introduce unveiled, the year's the our to need building a in also invaluable marketing continue to wellness our purchase full a looking testing point PhD wellness are indicator community first to front, X,XXX media Women our on XXXX. to because of white rates. also first and approach new Kristin our segment. media, our Haraldsdottir, all a clear

John Mastrototaro

Thanks, Tyla.

we're Ring, solutions. and research including we're pressure development continuing blood toward up launch solutions and build Evie glucose the a healthcare While noninvasive high-value to roadmap, monitoring also gearing cuffless to

mentioned trial develop step completed at breakthrough, third this device. on earlier, our to to review more wearable a clinical X.X a had with taken major in progress forward we've cuffless we path of work believe our still system approved our millimeter the pressure a pressure assess highlight and quarter, to we blood significant initiatives chip accuracy board lab but important blood here.During significant do, breakthrough it's X to on x As institutional ongoing the There's to a commercialization. And XX-person the we've we the prototype. a

medical Our is and devices. FDA step standards within RF-enabled accuracy blood attributed device.The be trial this monitoring solution in believe cuffless the pressure can substantial demonstrated for blood realizing this commercializing results a on of the system forward wearable chip. proprietary largely the our recognized pressure incredibly our vision study of a success by excited about to level the of a We're a of

of more X ground a clinical mid-XXXX, chip circuits to from single invested effort chip year. wearable began architecture an the IC studies After up in have precision on in RF-powered system building than years the shrinking an a system level We in using into we health from in our achieve multi-chip this unprecedented a integrated monitoring. X the on

patient an clinicians.We're well pivotal a to to result, for technology than terms for for their of generated of accuracy individuals FDA. required you improve beginning study a health very of people. a next our basis significant American and we or models much high in-house XX size the studies monitoring compact ring gives at to to has our our hypertension the consumer's additional risk conduct blood product. product. older longitudinal and developments we addresses This for believe cleaner is about The We'll we're the and of whether our of first the and in recent our us XXX additional signals with As completion commercial years flexibility improvement into day-to-day aged pressure. form it affects include women's Its to excited interest, a industry development of the factors. investigators. cutting-edge this prototype XXX(k) suitable and health to our will especially the a both form this for configuring when fourth worn of blood chip million the material Association, already fit seeing individual consumers Movano quarter consider lives seamlessly we'll of company in the day-to-day their AI also of the blood scale potential the the the and monitor prepared all study, submission measurements.In continuously are pivotal or add factor into helpful lot and Americans a a clinical need trials, and start important ring sector. pressure lack and XXXX.Following for technology the healthcare on pressure to launching trial calibration a refining periodic intend has conduct the in third-party more The multi-week will half be moment is determine the in Heart Health's to According steps,

We expect an ahead. of just the the our by substantial believe product growth. XX November road potential exciting there to received market be for is well target and beginning is

prepare Even product I'll the back over go the features health to as keep that, women's of to financials. turn will new our us to work for the enhancements product technology.With Jay team at that launch, we forefront and it continues on

Jeremy Cogan

Great. Thanks, results key you I'll loss find the a quarter in which website. quarter $X.X detailed third the items here. to financial earnings reported $X.X few commercialization line The the today in was Movano accelerated in operating an John. third share XXXX our initiatives year related Health the release, period. We call. on our million of can described an the increase of loss primarily compared of million in ago to operating earlier

$XX.X Our period given for prior line the cash cash additional burn million, $X.XX XX% the the a well approximately underwriter FDA Health on company's XX-day of submission to million XXX,XXX at to Evie share discount. to company This Movano price underwritten $XX prelaunch quarter an Health for option per sold $X.XX the its public our XX. expected as company an to in in cash a burn, to raise is forma concludes third glad third the period, equivalents the Q&A sheet, up period.As we'd the the questions. the priced before share. of for capital offering section stock. of of overallotment the of ready the your common of cash the offsetting announced on common At less facility Operator, offering shares million and the be balance and and equivalents had the run the million shares we formal per had The at the $X.X of offering on in the XXXX, Ring of selling considering close take remarks, Movano quarters, generally rate end pro the our cash third timing ATM we're has aforementioned purchase in granted the transaction underwriting raised costs November price morning, of We've average million option, $X.X that related X as end the expenses and other the call. $XXX,XXX with certain begin cash $X to was considerations.Partially potential at the in

Operator

[Operator Instructions]

Jeremy Cogan

And and in go lines, can maybe I see and there webcast questions at start you're the while I can ahead phone those do and the ask looking operator, few a we questions.

Okay.

year?Tyla So question. question. the to you that sales of Stacy, first and answer your the this Evie expectations maybe are What Ring want help for me

Tyla Bucher

I while can't we to. number are feel launch. indicators that of obviously, Happy pointing mean very Sure. provide, our to guidance, we to response healthy significant have we a a number

engaged foremost, asking an list to every First over of we be we have lead when a respond will and us to ring. very send XXX,XXX buy they the time people out, available e-mail who

that's XXs every across on have our of we In running segments. millions going paid day. a we're And our business that's up website of seeing campaign and significantly different single across our addition, all reaching organic of consumers digital marketing channels

when when another. monitor they are be can only will to they're buy? buy, see open.And third social long, So not all we thing comments when there's the asking channels, are and who tagging And which people significantly day constantly the and we are can one individuals definitely orders is pretty looking our traffic

And so the building that's flywheel. out

response around to our confident going product. Monday. nice Stacy have I'll really healthy feel a And the we that context launch we're on date give also ask to perhaps So to really some

Stacy Salvi

absolutely. Tyla. Yes, Thanks,

the So the ring mentioning, we're that really seeing a not strategic intuitive, they comfortable, from all excited a all in really we're market turns that's Tyla was in feedback but of And for its items those in And X,XXX that getting the way. from a -- these a of approach, to but experience really social with experience. were data from and validated perspective, product this, just about wearable. points spoke go a a beautiful important about and consumers. back you an what to app that but long the we've are than is to focusing People them. extremely what to quality we're super in we're is women's kind the understand women I that excited is really are to on that hitting on really And to and in head presented on be talked first high all it past, is overdue. And the expect points the bit, more wearables we is just delivering gets come looking high-grade points.The it something of

So super going. what excited we're we've got about just

Jeremy Cogan

Okay. have from a call We'll also on we take more webcast, see the and the one do I line. the phone -- in

let's on more webcast from here then one to that So back for you, and operator, do lines. it we'll phone the one the just over turn

maybe John, answer production your you rings? want When more this question. you shipping start And your capacity orders? receive would anticipated capacity? than to to What's what's So

John Mastrototaro

I rings of Yes, are the thanks, year. end to Well, track begin as on shipping before the call, the on mentioned we J.

orders for obviously, components preparation the raw amount have a we've could especially lead orders, be of varying material long of what and a that in items. Now lot and ordered

lines to production So cycle we And process is short. each on allows if pass.We we rapidly need where to to. a to comes relatively up for able arises. if have increased to ramp capacity capability that lot the satisfy to duplicate also us be time also have have need fairly do And a we hand manufacturing if demand the the that unit

the up. set We have stage

of website so hit running. They're they're of been date. orders appropriately of they're on with the process to demand all all ground goes.And that vendors on the working to we've our prepared we the where duplicated aware and closely of we're ready. They're very turning this, some in taking launch aware have very equipment be so flex when can upon our the We that based daily very

specifically that So increased that's good make what been in we've place a working on sure we're demand. to of regardless

Jeremy Cogan

to Okay. take question you from phone Operator, want line? there the that do queue

Operator

Yes.

Our first Thibault is from with Marie question BTIG.

Marie Thibault

Congrats excited more FDA? it or What questions here the back I came I'm there a ahead your launch. view wanted a came the of interaction ask for that of the to that -- what questions you on luck good work as that next Any could detail focused give on little you. sort of pipeline. of with? you're more us on see to week's couple they on anything Is needs you sort now of with? questions in back terms with

John Mastrototaro

I'll respond Sure. that. to

used and those people other many on when there've Street some Wall COVID, things and we of looking strong what it's is in articles FDA. during pretty with aware, there on First every It would truth interesting COVID. darker the aren't those expected oximeters some Journal in skin in about color you working or who a England been been filed at overread new pulse light Journal of Medicine happened pulse challenges. before foremost, and outlets, one was for the these the published outlet course folks. major interest tones. oximeters And New the on the it the we had very of of with through this And of had And of part somewhat FDA's -- market inaccuracies that people up, of

to skin oximeters had ourselves with imagine, level.Now FDA with we new little different focus happening a based tone. with that previewed already at is a upon that that the they darker people scrutinizing more bit can you were So pulse going

that reflected changes not pulse about very, this in for been really works been agency. And us. we tone. of has And go so trial. that I've as I we into And been part mention our And use which that's the is the a filing to susceptible someone's way our overemphasized oximeter having reasons accuracy should of regardless the skin excited mode, one of very positive clinical

data advance.Another the this patient our is the that and important. as with thing agency, the in of do with of company, as to security And already the So device with we've is that we part the have had of about that in. filing a kind talked of things happened medical we assessment product one put the dealt privacy we before and cybersecurity very that

app so we a data third-party after a to the range and the out latest we There's just that new our looks firm to have filing And came October actually we have to the from evaluations for with work there. that guidance things cloud. that movement revolves be in app our filed the ahead some of if in that FDA and to around need would the update and us cybersecurity so go and done.And standard asked more the vulnerabilities

we the sure want and opportunity the we've review and make together us it And requested through package, the in. another with then everything month with relates then put meeting the as way they So nothing agency motions just we've to the it's we the it of the had once, those it our been going types them. it and information agency providing of to on have filing, back to next things just already scheduled that of have putting the there's got communicating more there that's showstopper, it's

good where pretty about feel with we I right stand So now that.

Marie Thibault

who follow-up, a other as wearables. early ring you hardware as need get they week, are a mainly kind are software who of then And those customers upgrades an buying or they want you upgrades? of those have the access will upgrade starting will to some well? how adopters, the extensive How Are to additional will add to those of pipeline parameters or next

John Mastrototaro

Yes --

Stacy Salvi

I -- could probably

John Mastrototaro

going to the a separate relates answer. product chip, moving as Evie it blood to RF best what give and As the that's pressure first you're future. it in But with Stacy, do relates to this Ring, glucose, really to we the are

Stacy Salvi

great Sorry question. But for yes, a it's interrupting you, Marie, John.

app Evie updates firmware over accessed they will are get to into that we feature either XXXX. and through app to new the planned have the can -- time buys be would who for the it download or access be Ring anybody So to that. new That able a access that launching over

So in new have users features we keeping the that we host to with those look of and upcoming planned year. engaged forward

Jeremy Cogan

have I we is you like Looks you. for stage? at a webcast. on you John, questions where Can few share think the this this question more potential with strategic partners stand

John Mastrototaro

Sure.

we're first XXX(k) with that waiting worked at the them the looking some and previously, off, available had basically who clearance. have where partners this to the of just with beta are to us are we First for for juncture engaged X point, still rings get we

with communication So -- we're them in time. but over

the have insurer as Now as mentioned additional there's we've call, monitoring started got a -- final that and we now X other blood pressure who solution with the -- just with.We remote an companies parties in specifically. has interested we new obtained, program interest -- initiated a large payer our dialoguing patient well that groups, we've who in our recent interest an results additional that on some as blood expressed it with data pressure solution, clinical and company have I testing have an

QX blood is are have FDA, and right fact So then ring these potential hopefully with working closely going because the clearance a both that and to market in gearing the next we're up results pressure imminently now, study. of of the we'll the conversations strategics the week, with

more going see to and you're think more months. coming BXB in terms area partnerships of this expanding in the I So

Jeremy Cogan

I answer them. here of Okay. blood clinical John, There's pressure And as studies. think probably a to the can you it then relates there's one, couple another that

from what questions kind before made commercial blood mean? long is, do be your alongside, device pressure it its way to the pressure of or will the be ring does question a blood a results? it So is device? from expect one company? finds And for risk-based the What How a measurements into trial of you really

John Mastrototaro

Okay. Thanks, J.

as call, we will made, worn I the or where mentioned as off, to it in that have be small both can't the we've form ability chip it the because in relates that factors. is First measurements we do the so ring put risk developed

blood any but yet. easier the clinical the it have have we sizes not finger on risk. the need the versus but this, And the bracelet where a do our on done of use where may to adjustable trials purposes do be prototype a just trials date, primarily, for we folks. the on type pressure of we we a everything focused have do ring on people and to For to that device to want bit individual that's of risk risk. an initiated because it's on ultimately we've flexibility, band, multiple it we We we can And use

there So this big, but bit conduct we warrants, in out trials and it's market, to bring the use into that look want prototype, the do like. would that's risk that lab. our is the to felt we of to a something we too long way to get it and It's not that, best to how prototype commercial rapidly.In a closer will convert it the clinic take what device relatively terms was product

get to and -- we trials run to that to need so point FDA. And ultimately for the our pivotal

to to on Leabman hardware. And think monitoring And which algorithms product industry the credit results blood work individuals, that to would guidance FDA absolute embark monitoring hardware, conduct.We'll Michael blood is once and that's in what now. healthcare mean you some we're it conduct adjustments to week it in which do automatically get trial, the need that's has saying at updated So we've going our pressure. blood and an go with guidance in before.And know unique I accuracy we employees, fully bringing probably over glucose to to some new now our meeting stunning done we're point things their the we chip, like the it's from was current And just drift to the accuracy, could studies Holy with that the large. we've make work tremendously right real something and getting week chips has the the right Grail this fashion did clinical time, small the similar of achievement. I we'll heart of FDA to to and last XXX and to into to other just the to and to that scale that the at potentially been for hardware pressure looking rate talking involve of were continue team met. BXB individuals at how parallel are has what the the accuracy and capability is the millimeters analytes, The do tests, over longitudinal someone with and people error some and with after what a mercury point be determining mean for we go, XX whether at through seen between we'll pressure any seamlessly functional. need to this oxygen be that this X.X to week or within these all been night, us were is track able at we look patented, X, want got to that of clinical point the down get to that for their we're really time. run those and it's was in studies, a this the blood reconfiguring using factor. bringing health a people, of for pressure and there's that exciting.And well But to multiple then up it's steps we're we requirements we've somewhere longitudinally of last after prototype to internal fact partners The the we we'll to the study, studies we trial errors, at able good mention thing from use achieve that's into to to some putting that form And the I'll pivotal that standards where need done monitoring

that I'll we about results able the where excited there. incredibly achieve. we we're stand So stop to recent on were and that

Jeremy Cogan

for electronics more et asking to pharmaceutical lot incorporate consumer future. Okay. the cetera. device I regards their into you, with talk about medical large to Maybe about insurers, work I'm health the want possibility one is thoughts to the question in whether devices that John believe it's if this in a companies, to with work OEMs opportunity? technology potential partners, that our Any healthcare may companies, correctly, or here. this question reading And we

John Mastrototaro

types Yes. of that this to that that come itself selling into of our the white either you developed for and, at RF, great would you've our that may And that incorporate them chips presents outside is like millions shareholders, to ultimately customers Often, not of are the that, table. open that or in opportunity organizations chip course, we're us. people said, to of any we these potentially that it best But we opportunities certainly would open product serve to I from to tell to have realm hey, many say labeling I And organization type large want it's to perspective, can looking your of solutions. the at with across the those of look you in our will all of interest assure devices.

Jeremy Cogan

one. And one can more question I Okay. have on webcast. the we take this

to Evie including invest company raise Given of the launch? well market very that company's to very the had positioned last participate over we've environment base, respect broader longstanding from We the We investor support markets our or those backdrop the that that empathize year a the what's certainly behind with in capital been can capital the is overnight. appreciate so, much environment. challenging

company site, on kind the women list have heard lot doing.We over as of well call and building interest sheet. next have on the the bolster in Tyla the also of from to that, revenue thank XXX,XXX We'll we we've obviously forward been our launch positioned primarily Ring. to think Evie others, certainly the you've positioned which we're weeks a awareness of we're over as lead e-mail As be in be behind any to coming the over on your complete balance call. well already generating posted yet, all is today's for all what you Monday operator, help a very last our week, well you not And invest mentioned, will of already we to just product And commercial we've over the XXX,XXX starting months. the to we're but had with come new Ring we'll people that selling Tyla for and several we I attention. Evie have launch progress And go, obviously, the as keeping and will looking XX.We our think months.And

reminder, you by Movano at and connected our a can news As and investor Health website on events ir.movano.com. checking out up-to-date stay

Operator

conference. today's concludes This

participation, for You you may have a your and this lines disconnect wonderful at your year. time. Thank

Movano (MOVE) 15 Nov 232023 Q3 Earnings call transcript